Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 38.21%6.58B | 40.97%21.96B | 32.94%4.76B | 37.10%15.58B | 23.53%4.19B | 43.15%3.88B | 49.09%3.94B | 36.34%3.58B | 62.48%11.36B | 31.49%3.39B |
| Cost of revenue | 173.52%2.08B | 12.45%3.14B | 10.64%759M | 38.02%2.79B | 44.99%767M | 37.25%689M | 64.12%645M | 15.29%686M | 51.54%2.02B | 39.58%529M |
| Gross profit | 12.53%4.5B | 47.20%18.83B | 38.23%4B | 36.90%12.79B | 19.57%3.42B | 44.49%3.19B | 46.42%3.29B | 42.58%2.89B | 65.07%9.34B | 30.10%2.86B |
| Operating expense | 22.13%3.73B | 50.18%15.88B | 29.35%3.05B | 38.33%10.57B | 30.23%2.98B | 50.00%2.81B | 34.53%2.43B | 40.54%2.36B | 51.07%7.64B | 23.17%2.29B |
| Selling and administrative expenses | 12.00%3.7B | 49.00%16.15B | 39.11%3.3B | 42.37%10.84B | 34.11%3B | 55.08%2.86B | 41.94%2.61B | 40.00%2.37B | 48.95%7.61B | 20.04%2.24B |
| -General and administrative expense | 12.00%3.7B | 49.00%16.15B | 39.11%3.3B | 42.37%10.84B | 34.11%3B | 55.08%2.86B | 41.94%2.61B | 40.00%2.37B | 48.95%7.61B | 20.04%2.24B |
| Other operating expenses | 245.45%76M | -2.00%49M | 175.00%22M | -47.37%50M | -75.68%9M | -87.23%6M | 420.00%26M | 100.00%8M | 280.00%95M | 428.57%37M |
| Total other operating income | -84.01%43M | 1.27%319M | 1,245.00%269M | 392.19%315M | 500.00%36M | 231.25%53M | 454.05%205M | 5.26%20M | -15.79%64M | -152.94%-9M |
| Operating profit | -18.52%770M | 32.97%2.95B | 77.63%945M | 30.49%2.22B | -22.78%444M | 13.51%378M | 94.81%863M | 52.44%532M | 183.17%1.7B | 67.64%575M |
| Net non-operating interest income (expenses) | -12.50%-18M | 22.54%-55M | -14.29%-16M | -77.50%-71M | 7.69%-12M | -107.69%-27M | -41.67%-17M | -1,300.00%-14M | -14.29%-40M | 7.14%-13M |
| Non-operating interest income | 0.00%1M | --28M | --1M | --0 | --0 | --0 | --0 | --0 | 57.14%11M | --0 |
| Non-operating interest expense | 11.76%19M | 16.90%83M | 21.43%17M | 39.22%71M | -7.69%12M | 107.69%27M | 41.67%17M | 16.67%14M | 21.43%51M | -7.14%13M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 60M | 39M | 0 | |||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -12.69%812M | 36.63%2.93B | 79.54%930M | 29.43%2.15B | -22.99%432M | 9.40%349M | 97.20%846M | 48.85%518M | 193.97%1.66B | 71.56%561M |
| Income tax | -35.41%239M | 41.96%1.06B | 78.74%370M | 75.12%746M | -50.86%86M | 101.35%149M | 163.48%303M | 245.00%207M | 114.07%426M | 41.13%175M |
| Net income | 0.88%572M | 22.96%1.88B | 82.32%567M | 24.11%1.53B | 23.00%476M | -18.44%199M | 72.61%542M | 8.36%311M | 237.53%1.23B | 90.64%387M |
| Net income continuous operations | 2.33%572M | 33.81%1.87B | 79.74%559M | 13.56%1.4B | -10.59%346M | -18.44%199M | 72.61%542M | 8.36%311M | 237.53%1.23B | 90.64%387M |
| Net income discontinuous operations | --0 | -93.85%8M | --8M | --130M | ---- | ---- | ---- | ---- | ---- | ---- |
| Noncontrolling interests | 0 | -108.11%-6M | -104.35%-2M | -52.87%74M | -97.56%1M | -63.27%18M | -10.00%9M | -16.36%46M | 390.63%157M | 28.13%41M |
| Net income attributable to the company | 0.18%572M | 29.60%1.89B | 116.29%571M | 35.57%1.46B | 37.97%476M | -6.70%181M | 75.91%533M | 14.29%264M | 223.49%1.07B | 102.94%345M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 0.18%572M | 29.60%1.89B | 116.29%571M | 35.57%1.46B | 37.97%476M | -6.70%181M | 75.91%533M | 14.29%264M | 223.49%1.07B | 102.94%345M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -0.72%42.99 | 20.53%142.5 | 84.26%43.3 | 22.43%118.23 | 19.34%37.02 | -20.32%13.96 | 63.19%44.78 | 13.91%23.5 | 232.66%96.57 | 108.89%31.02 |
| Diluted earnings per share | 0.05%42.22 | 22.43%139.56 | 89.66%42.2 | 22.49%113.99 | 23.08%36.05 | -20.29%13.51 | 60.87%43.13 | 10.70%22.25 | 230.82%93.06 | 103.40%29.29 |
| Dividend per share | 0 | 25.00%2.5 | 0 | 2 | 2 | |||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |